Bio Essence Corporation
BIOE · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $9,160 | $18,337 | $18,155 | $16,505 |
| - Cash | $1 | $0 | $6 | $0 |
| + Debt | $2,705 | $3,479 | $4,619 | $3,963 |
| Enterprise Value | $11,864 | $21,816 | $22,768 | $20,467 |
| Revenue | $324 | $552 | $622 | $888 |
| % Growth | -41.3% | -11.3% | -30% | – |
| Gross Profit | $217 | $277 | $328 | $298 |
| % Margin | 67% | 50.3% | 52.8% | 33.6% |
| EBITDA | -$1,562 | -$765 | -$497 | -$560 |
| % Margin | -482.1% | -138.7% | -79.9% | -63.1% |
| Net Income | -$1,309 | -$972 | -$810 | -$648 |
| % Margin | -404% | -176.2% | -130.3% | -72.9% |
| EPS Diluted | -0.034 | -0.022 | -0.025 | -0.02 |
| % Growth | -54.3% | 9% | -25% | – |
| Operating Cash Flow | $624 | -$1,026 | -$703 | -$1,294 |
| Capital Expenditures | -$0 | -$4 | -$59 | -$119 |
| Free Cash Flow | $624 | -$1,029 | -$707 | -$1,414 |